Business

ADIA Nutrition Appoints Dawn Bell as Chief Revenue Officer to Accelerate Growth and Drive Success Across Physician Network

Winter Park, Florida--(Newsfile Corp. - January 8, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a rapidly growing leader in regenerative medicine, today announced the appointment of Dawn Bell as Chief Revenue Officer (CRO) through its subsidiary, ADIA Labs. Ms. Bell brings more than 15 years of proven expertise as a sales strategist in the medical device and pharmaceutical industries, with a strong history of driving growth and building successful partnerships.Dawn BellTo view an enhanced version

articleAdia Nutrition, Inc.January 8, 20264/company/adia-nutrition-inc/news/adia-nutrition-appoints-dawn-bell-as-chief-revenue-officer-to-accelerate-growth-and-drive-success-across-physician-network
ADIA Nutrition Appoints Dawn Bell as Chief Revenue Officer to Accelerate Growth and Drive Success Across Physician Network

About this update from Adia Nutrition, Inc.

[{"type":"text","content":"Winter Park, Florida--(Newsfile Corp. - January 8, 2026) - ADIA Nutrition, Inc. (OTCQB: ADIA), a rapidly growing leader in regenerative medicine, today announced the appointment of Dawn Bell as Chief Revenue Officer (CRO) through its subsidiary, ADIA Labs. Ms. Bell brings more than 15 years of proven expertise as a sales strategist in the medical device and pharmaceutical industries, with a strong history of driving growth and building successful partnerships.","length":464,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":450,"height":773,"url":"https://media.zenfs.com/en/newsfile_64/e8c2ec550377042848ee61e76e2d2293"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ckEiqdbjcDchGoEvf36yGw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEyMTE7Y2Y9d2VicA--/https://media.zenfs.com/en/newsfile_64/e8c2ec550377042848ee61e76e2d2293","width":450,"height":773}},"href":"https://images.newsfilecorp.com/files/10520/279724_dawnbell.jpg","hrefExternal":true},{"type":"text","content":"Dawn Bell","length":9,"tagName":"p","attribs":{}},{"type":"text","content":"To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10520/279724_dawnbell.jpg","length":122,"tagName":"p","attribs":{}},{"type":"text","content":"While Ms. Bell's role includes strengthening revenue for ADIA Nutrition and its laboratory operations, her primary contribution will be ensuring shared success across the entire ecosystem. She will be partnering with doctors and clinics to significantly increase their revenue by providing hands-on guidance and proven strategies to seamlessly integrate the Company's advanced regenerative therapies and diagnostic services into their practices-whether in regenerative medicine, orthopedics, pain management, wellness, or other specialties.","length":548,"tagName":"p"},{"type":"text","content":"This appointment comes at an important time as Adia Med of Winter Park prepares to launch its first Institutional Review Board (IRB)-approved clinical study focused on autism, marking a significant advancement in the Company's clinical and scientific efforts.","length":263,"tagName":"p"},{"type":"text","content":""We are truly excited to welcome Dawn to the team," said Larry Powalisz, CEO of ADIA Nu...

More updates from Adia Nutrition, Inc.

ADIAregenerative medicineDawn BellADIA LabsBellWinter ParkAdia Medrevenue growthbuilding successful partnerships